These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1243126)

  • 21. Proceedings: CF 25-397 (9, 10-didehydro-6-methyl-8beta-(2-pyridylthiomethyl) ergoline), a new central dopamine receptor agonist.
    Jaton AL; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Mar; 56(3):371P. PubMed ID: 944059
    [No Abstract]   [Full Text] [Related]  

  • 22. Behavioral changes in 6-hydroxydopamine-treated rotation rats after delivery of various neuromodifying agents by means of a stereotactically implanted pellet to the brain.
    Yoshida M; Torigoe R; Ohtsuru K; Kuramoto S
    Stereotact Funct Neurosurg; 1990; 54-55():342-6. PubMed ID: 2127860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facilitation by alpha-adrenolytics of apomorphine gnawing behavior: depression of threshold apomorphine concentration in the striatum of the rat.
    Wiszniowska-Szafraniec G; Danek L; Reichenberg K; Vetulani J
    Pharmacol Biochem Behav; 1983 Jul; 19(1):19-21. PubMed ID: 6226051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of central dopaminergic receptors of morphine: effect of haloperidol, apomorphine or benztropine.
    Puri SK; Reddy C; Lal H
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):389-401. PubMed ID: 4735501
    [No Abstract]   [Full Text] [Related]  

  • 25. Supersensitivity of the cholinergic response to apomorphine in the striatum following denervation or disuse supersensitivity of dopaminergic receptors in the rat.
    Consolo S; Ladinsky H; Samanin R; Bianchi S; Ghezzi D
    Brain Res; 1978 Oct; 155(1):45-54. PubMed ID: 210895
    [No Abstract]   [Full Text] [Related]  

  • 26. Behavioral effects of direct- and indirect-acting dopaminergic agonists.
    Moore KE
    Adv Biochem Psychopharmacol; 1974; 12(0):403-14. PubMed ID: 4371765
    [No Abstract]   [Full Text] [Related]  

  • 27. Dopaminergic-cholinergic interactions in naloxone-induced circling in morphine-dependent rats with nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    Eur J Pharmacol; 1976 Jul; 38(1):39-54. PubMed ID: 986306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neurophysiologic and pharmacologic evidence of autoregulationin the nigrostriatal system].
    Arushanian EB; Tolpyshev BA
    Biull Eksp Biol Med; 1981 Feb; 91(2):133-6. PubMed ID: 7194700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circling behavior in normoxic or hypoxic rats with unilateral 6-OHDA nigrostriatal lesion. Part 1. Effects of apomorphine and L-dopa.
    Saligaut C; Daoust M; Moore N; Boismare F
    Methods Find Exp Clin Pharmacol; 1987 Apr; 9(4):219-24. PubMed ID: 3110513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent.
    Johnson AM; Vigouret JM; Loew DM
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R40. PubMed ID: 4276573
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of telencephalic dopaminergic systems in the mediation of apomorphine-stereotyped behaviour.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1973 Oct; 24(1):8-24. PubMed ID: 4796448
    [No Abstract]   [Full Text] [Related]  

  • 32. The neurological basis of motor asymmetry following unilateral nigrostriatal lesions in the rat: the effect of secondary superior colliculus lesions.
    Crossman AR; Sambrook MA
    Brain Res; 1978 Dec; 159(1):211-3. PubMed ID: 569529
    [No Abstract]   [Full Text] [Related]  

  • 33. Striatal efferent fibers play a role in maintaining rotational behavior in the rat.
    Marshall JF; Ungerstedt U
    Science; 1977 Oct; 198(4312):62-4. PubMed ID: 897683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of the central dopaminergic stimulants apomorphine and lergotrile.
    Wade RL; Krewsun I; Quock RM
    Proc West Pharmacol Soc; 1979; 22():141-2. PubMed ID: 42079
    [No Abstract]   [Full Text] [Related]  

  • 35. Behavioral activity of some novel aporphines in rats with 6-hydroxydopamine lesions of caudate or nucleus accumbens.
    Jackson EA; Neumeyer JL; Kelly PH
    Eur J Pharmacol; 1983 Jan; 87(1):15-23. PubMed ID: 6404639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circling behaviour induced by dopamine releasers and/or uptake inhibitors during degeneration of the nigrostriatal pathway.
    Oberlander C; Euvrard C; Dumont C; Boissier JR
    Eur J Pharmacol; 1979 Dec; 60(2-3):163-70. PubMed ID: 575095
    [No Abstract]   [Full Text] [Related]  

  • 37. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ; György L
    Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.
    Schwarcz R; Fuxe K; Agnati LF; Hökfelt T; Coyle JT
    Brain Res; 1979 Jul; 170(3):485-95. PubMed ID: 37986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rotatory behavior induced in nigra-lesioned rats by N-propylnoraporphine, apomorphine, and levodopa.
    Mendez JS; Cotzias GC; Finn BW; Dahl K
    Life Sci; 1975 Jun; 16(11):1737-42. PubMed ID: 1143000
    [No Abstract]   [Full Text] [Related]  

  • 40. The substantia nigra and stereotyped behaviour.
    Costall B; Naylor RJ; Olley JE
    Eur J Pharmacol; 1972 Apr; 18(1):95-106. PubMed ID: 4555563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.